We examined effects of topically applied dopamine on pial arteriolar diameter and CSF prostanoid levels in newborn pigs. Vascular responses were deter mined using the closed cranial window technique and in travital microscopy, and prostanoids were determined by radioimmunoassay. Topical application of dopamine did
not change arteriolar diameter at 10-7_10-5 M, but con stricted arterioles at 10-4 ( 16%) and 10-3 M (30%). In travenous administration of indomethacin (5 mg/kg) did Dopaminergic neural systems have a widespread distribution in the brain (Ungerstedt, 1971 ; Lindvall and Bjorklund, 1978; Reader et aI., 1979) , and dopamine is thought to play a role in regulation of cerebrovascular tone (Edvinsson et aI., 1978; Al tura et aI., 1980; McCulloch, 1984; Harik et aI., 1986) . We have shown that several other neuro transmitters, including norepinephrine, acetylcho line, and histamine, increase levels of prostanoids in CSF of piglets (Busija and Leffler, 1987a; Busija et aI., 1988; Mirro et aI., 1988) . Furthermore, block ade of prostanoid synthesis was able to modify vas cular responses to these neural stimuli (Busija and Leffler 1987a; Wagerle and Busija, 1989 ; Mirro et aI., 1988) . Whether dopamine can affect prostanoid synthesis by cerebral tissues and/or blood vessels is unclear. Millia et ai. (1983) have reported that apo morphine increases prostanoid levels in the cerebel lum in rats, but in that study changes in brain pros tanoids were not correlated with cerebral hemody namics.
The purpose of this study was to examine rela-not alter this constriction. In addition, CSF prostanoid levels did not increase in response to application of dopamine except for a modest increase of prostaglandin Ez at 10-3 M. We conclude that dopamine is a constrictor at high doses of piglet pial arterioles and that this re sponse is not modified by endogenous prostanoids. Key Words: Cerebral vessels-Prostaglandin Ez-Prosta glandin Fz",-Prostacyclin-Catecholamines.
tionships among dopamine, cerebral microvascular tone, and prostanoid production in the brain. We tested the hypotheses that dopamine would con strict pial arterioles and increase levels of pros tanoids in CSF of piglets, and that prostanoids would contribute to the final cerebrovascular re sponses observed.
METHODS
Thirteen piglets of either sex, 1-5 days of age, initially were anesthetized with ketamine hydrochloride and ace promazine (33 and 3.3 mg/kg, i.m., respectively), fol lowed by a-chloralose (50 mg/kg i.v. initially, plus 5-10 mg/kg/h). Catheters were placed into a femoral artery to record blood pressure and to sample for gases and pH, and into a femoral vein for injection of drugs and fluids. The animals were intubated and ventilated with air. Body temperature was maintained at 37-38°C using a water circulating rubber heating pad. After the scalp was re moved, a hole 2 cm in diameter was made in the skull over the parietal cortex. The dura and arachnoid mem branes were cut without touching the brain, and all cut edges were reflected over the bone. A stainless steel and glass cranial window was placed in the hole and was ce mented to the skull with dental acrylic (Busija and Lef fler, 1987a). The space under the window was filled, through needles incorporated into the sides of the win dows, with artificial CSF of the following composition: 220 mg KCI, 132 mg MgClz, 221 mg CaClz, 7,710 mg NaCl, 402 mg urea, 665 mg dextrose, 2,066 mg NaHC03, Hg; P0 2 = 43 mm Hg. The volume of fluid directly under the window was =500 J-li and was continuous with the subarachnoid space. Pial arterioles were observed with a Wild trinocular stereomicroscope. Pial arteriolar diame ter was measured with a television camera mounted on the microscope, a video monitor, and a video microscaler (model VPA-loo, FOR-A-Corporation).
Experimental design
The cranial window was flushed several times at 5-min intervals. The diameter of one pial arteriole was mea sured in each animal. Five minutes after the last flush, cerebral surface CSF ( 300 J-ll) was collected by placing a syringe containing CSF on one of the needles of the win dow and infusing CSF, while collecting from another nee dle. Then dopamine (3-hydroxytyramine; Sigma Chemi cal Co., St. Louis, MO, U.S.A.) in 5 ascending doses ( 10-7,10-6, 10-5 , 10-4, and 10-3 M) was infused under the window. Arterial diameter was measured at each dose, and CSF was collected after 5 min. Maximal changes in diameter were recorded, which usually oc curred at 1-3 min after infusion. This protocol was re peated 20-30 min after administration of indomethacin (5 mglkg, i.v.). We have shown previously that this dose of indomethacin reduces basal levels of CSF prostanoids to nondetectable levels and abolishes increases in CSF lev els of prostanoids to a number of stimuli, including arachidonic acid Busija, 1985a, 1985b) .
Eicosanoid analysis
Prostanoid levels in CSF for 6-keto-prostaglandin F 1a (6-keto-PGFt a , the hydrolysis product of prostacyclin), prostaglandin E 2 (PGE 2 ), and prostaglandin F 2 a (PGF 2 a), were determined by radioimmunoassay (Busija and Lef fler, 1987a). Antibodies to prostanoids were produced in rabbits immunized with prostanoids coupled to thyro globulin using the mixed anhydride method. Cross reactivities of our antibodies with other known, biologi cally relevant prostanoids tested were all < 1 %. The as says were performed in gelatin (Tris) buffer using the appropriate tritiated prostanoid. After 24-h incubation at 4°C, the free fraction was separated from the fraction bound to antibody using dextran-coated charcoal. Data were handled by computer, with determination of second-order regression of tracer bound to antibody against un labeled prostanoid by the method of least squares. All unknowns were assayed at three dilutions, with parallel ism between the unknown dilution curve and the standard curve required before the result was used. Sample dilu tions used in the present study allowed analysis of pros tanoid concentrations between 100 and 50,000 pg/ml.
Statistical analysis
All values are presented as means ± SEM. We exam ined effects of dopamine on pial arteriolar diameter and CSF prostanoids using repeated measures analysis of variance followed by pair-wise comparisons (Student Newman-Keuls test) when necessary. When the pros tanoid concentration was below the detection limit of the assay (8 cases of 174), a value of 100 pg/ml was assigned to allow statistical analysis. For comparison of diameter values in the presence of dopamine before and after in domethacin, we used paired t tests comparing percent change from control for 10-4 and 10-3 M dopamine. An a-level of p < 0.05 was used in all statistical tests.
RESULTS
Dopamine did not change arteriolar diameter at 10-7, 10-6, or 10-5 M, but decreased diameter at 10-4 (16%) and 10-3 M (30%) (Table O. Further more, dopamine did not change CSF levels of PGF20( or 6-keto-PGF)0( at any dose, but increased levels of PGE2 twofold at 10-3 M dopamine ( Table  1) . Arterial blood gases were: pH 7.57 ± 0.03, Pco2 31 ± 1 mm Hg, and P02 92 ± 3 mm Hg.
Before indomethacin administration, diameters were 176 ± 31 j.Lm during control, 146 ± 25 j.Lm . There was no significant difference in responsiveness to dopa mine before and after indomethacin administration.
DISCUSSION
The major findings of the present study are that dopamine is primarily a constrictor of piglet pial arterioles and that endogenous prostaglandins do not modulate cerebrovascular effects of dopamine.
Dopamine-containing nerve fibers are widely dis tributed in the brain, including the cerebral cortex (Ungerstedt, 1971 ; Lindvall and Bjorklund, 1978; Bjorklund et al., 1978; Reader et aI., 1979) . How ever, dopaminergic nerves do not appear to directly innervate cerebral vessels (Felton and Crutcher, 1979) . The tone of cerebral resistance vessels could be influenced by dopamine in three ways. First, ac tivation of dopaminergic pathways may increase ce rebral blood flow via a metabolic mechanism (Mc Culloch, 1984). Second, during pathological condi tions, such as cerebral ischemia, dopamine release from neurons may be so great as to enable this neu rotransmitter to reach high extracellular levels and to have direct effects on cerebral resistance vessels (Harik et al., 1986 ; Bentue-Ferrer et al., 1986; Slivka et al., 1988) . Third, exogenous dopamine, given particularly to sick neonates to maintain car diovascular function, may have access to cerebro vascular smooth muscle due to either an immature or damaged blood-brain barrier.
Although low doses of dopamine tended to dilate piglet pial arterioles, the predominant response was constriction (up to 30%) at higher doses. The con strictor responses are similar to those reported by others for in vivo and in vitro studies (Edvinsson et al., 1978; Altura et aI., 1980; Oudart et al., 1982; McCulloch, 1984; Jauzac et al., 1982) . However, piglet pial arterioles were considerably less sensi tive than were cerebral vessels from adult cats. Whether this difference is due to species or age variation is unclear. Edvinsson et al. (1978) and Mc Culloch (1984) have shown that the constrictor re sponse to dopamine can be due either to activation of a-adrenoceptor or serotonergic receptors. It seems likely that the dopamine-induced decrease in diameter is due to activation of a-adrenoceptors be cause piglet pial arterioles constrict in response to exogenous and endogenous norepinephrine Leffler, 1987b, 1987c ) but do not constrict in response to serotonin (Busija and Leffler, unpub lished observations).
Dopamine did not increase prostaglandin levels in CSF except at the highest dose (10-3 M), which increased PGE2• Furthermore, this increase in J Cereb Blood Flow Metab, Vol. 9, No. 3, 1989 PGE2 levels was modest and less than one-third of the value caused by 10-4 M norepinephrine. Thus, it is not surprising that pretreatment with indo methacin did not potentiate constrictor responses to dopamine. These findings lend support to the con cept that interactions between PGs and neurotrans mitters are complex and neurotransmitter-specific. For example, topical norepinephrine increases CSF levels of prostanoids, and indomethacin pretreat ment unveils constriction at a subthreshold dose of norepinephrine (Busija and Leffler, 1987a ). In con trast, acetylcholine causes a massive increase in CSF prostanoid levels, and the cerebral vasocon striction caused by acetylcholine in piglets is abol ished by treatment with indomethacin (Busija et al., 1988; Wagerle and Busija, 1989) . Lastly, histamine induced cerebral vasodilation is associated with in creased CSF levels of prostanoids, and the vascular response is eliminated after treatment with indo methacin (Mirro et al., 1988) .
In summary, dopamine did not significantly in crease pial arteriolar diameter in piglets at lower doses (10-7 M, 10-6 M, 10-5 M), but constricted arterioles by 16% at 10-4 M and 30% at 10-3 M. Dopamine did not increase CSF levels of PGs, and indomethacin pretreatment did not enhance dopa mine-induced constriction. Thus, PGs do not ap pear to modulate cerebral microvascular effects of dopamine in piglets.
